David Charles Lubner, SVP and CFO at TETRAPHASE PHARMACEUTICALS INC (TTPH), sold 17,500 shares at $41.29 ($725K) on 2015-06-12, disclosed to the SEC on 2015-06-16.
Scheduled sale ($725k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.29 | 10,000 | $413K | 56.9% |
| 2 | $41.67 | 7,500 | $313K | 43.1% |
| Total | $41.45 avg | 17,500 | $725K | 100% |
| Filing → |
| PNT | BUY | 2022-11-28 | $25K | — | Filing → |
| TTPH | SELL | 2015-08-17 | $408K | — | Filing → |
| TTPH | SELL | 2015-07-15 | $367K | — | Filing → |